Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy Trial of Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells (HPCs) for Globin Gene Transfer in Patients with Sickle Cell Disease

Farid Boulad, MD, Tsiporah B. Shore, MD, Koen Van Besien, MD PhD, Danielle Guarneri, June Greenberg, RN, Caterina Minniti, MD, Sylvie wiener Fedus, Fabiana Perna, MD, Xiuyan Wang, PhD, Isabelle Riviere, PhD, Michel Sadelain, MD PhD, Patricia Shi, MD

Blood (2017) 130 (Supplement 1): 3531.

https://doi.org/10.1182/blood.V130.Suppl_1.3531.3531

Published: 2017

Journal Articles

Systematic Combinatorial Chimeric Antigen Receptor Therapies to AML

Fabiana Perna, MD, Samuel Berman, Rajesh K Soni, PhD, Jorge Mansilla-Soto, PhD, Justin Eyquem, PhD, Mohamad Hamieh, PhD, Ronald C Hendrickson, PhD, Cameron Brennan, MD, Michel Sadelain, MD PhD

Blood (2017) 130 (Supplement 1): 856.

https://doi.org/10.1182/blood.V130.Suppl_1.856.856

Published: 2017

Journal Articles

PRMT5 Methyltransferase Activity Is Required to Sustain Adult Hematopoiesis

Fan LIU, PhD, Guoyan Cheng, PhD, Fabiana Perna, MD PhD, Xu Haiming, PhD, Pierre-Jacques Hamard, PhD, Luisa Luciani, PhD, Stephen Nimer, MD

Blood (2014) 124 (21): 4335.

https://doi.org/10.1182/blood.V124.21.4335.4335

Published: 2014

Journal Articles

L3MBTL1: A Polycomb Protein At the Node of Crosstalk Between the BMP4 and Hippo Signaling Pathways in Erythropoiesis.

Fabiana Perna, MD, Ly P. Vu, Maria Themeli, MD, PhD, Ruben Hoya-Arias, PhD, Fan Liu, MD, PhD, Lan Wang, PhD, Nadia Gurvich, PhD, Todd Hricik, BS, Eirini P. Papapetrou, MD, PhD, Malcolm A.S. AS Moore, Ross L. Levine, Michel Sadelain, MD, PhD, Stephen Nimer, MD

Blood (2012) 120 (21): 2296.

https://doi.org/10.1182/blood.V120.21.2296.2296

Published: 2012

Journal Articles

IPS Cells From Del(7q)-MDS Patients Display Impaired Proliferation and Hematopoietic Commitment

Ibrahim Boussaad, PhD, Emily K Dolezal, Fabiana Perna, MD, Stephen D Nimer, MD, Eirini P Papapetrou, MD, PhD

Blood (2012) 120 (21): 174.

https://doi.org/10.1182/blood.V120.21.174.174

Published: 2012

Journal Articles

Regulation of AML1/RUNX1 Function by Protein Arginine Methyltransferase 4 (PRMT4) in Myeloid Differentiation

Ly P. Vu, Xinyang Zhao, PhD, Fabiana Perna, MD, Stephen D. Nimer, MD

Blood (2011) 118 (21): 549.

https://doi.org/10.1182/blood.V118.21.549.549

Published: 2011

Journal Articles

ASXL1 Mutations Promote Myeloid Transformation Through Inhibition of PRC2-Mediated Gene Repression

Omar Abdel-Wahab, MD, Mazhar Adli, PhD, Lindsay Saunders, B.Sc., Jie Gao, PhD, Alan H. Shih, MD, PhD, Suveg Pandey, B.Sc., Jake Jaffe, PhD, Xinyang Zhao, PhD, Fabiana Perna, MD, Martin Carroll, MD, Ari Melnick, MD, Stephen D. Nimer, MD, Iannis Aifantis, PhD, Bradley Bernstein, Ross L Levine, MD

Blood (2011) 118 (21): 405.

https://doi.org/10.1182/blood.V118.21.405.405

Published: 2011

Journal Articles

Targeting a Novel Epigenetic Silencing Mechanism to Efficiently Upregulate Fetal Globin Gene Expression

Fabiana Perna, MD, Ly P. Vu, Maria Themeli, MD, Ruben Hoya-Arias, PhD, Xinyang Zhao, PhD, Eirini P. Papapetrou, MD, PhD, Michel Sadelain, MD, PhD, Stephen D. Nimer, MD

Blood (2011) 118 (21): 352.

https://doi.org/10.1182/blood.V118.21.352.352

Published: 2011

Journal Articles

Methylation of RUNX1 by the Nuclear PRMT5/COPR5 Complex Regulates Its Cellular Location in Leukemia Cells,

Xinyang Zhao, Ph.D., Ly P. Vu, Fabiana Perna, MD, Fan Liu, MD, Hao Xu, Stephen Nimer

Blood (2011) 118 (21): 3403.

https://doi.org/10.1182/blood.V118.21.3403.3403

Published: 2011

Journal Articles

The Acetylation of AML1-ETO Is Required for Leukemogenesis.

Lan Wang, PhD, Alexander Gural, MD, Fabiana Perna, MD, Xiaojian Sun, PhD, Xinyang Zhao, PhD, Haiming Xu, PhD, Megan A Hatlen, Gang Huang, Ph.D., Fan Liu, PhD, Hao Xu, MD, Tony Deblasio, Silvia Menendez, Francesca Voza, Robert Roeder, PhD, Stephen Nimer, MD

Blood (2010) 116 (21): 1588.

https://doi.org/10.1182/blood.V116.21.1588.1588

Published: 2010

Journal Articles

Liposomal Cytarabine (Depocyte®) for the Treatment of Meningeal or CNS Disease in Acute Leukemias (AL) and Non-Hodgkin Lymphomas (NHL): A Single Centre Experience.

Andrea Camera, MD, Giuseppe Cerciello, MD, Fabiana Perna, MD, Ciro R. Rinaldi, MD, Elefanti Michele, Silvia Ferrari, Bruno Rotoli, MD

Blood (2006) 108 (11): 4540.

https://doi.org/10.1182/blood.V108.11.4540.4540

Published: 2006

Journal Articles

Subcutaneous Alemtuzumab as Treatment Option for Patients with Severe Aplastic Anemia or Lineage-Restricted Aplasia.

Antonio M. Risitano, MD, PhD, Carmine Selleri, MD, Andrea Camera, MD, Giovanni Gallotta, MD, Fabiana Perna, MD, Giampaolo Copeta, MD, Bruno Rotoli, MD

Blood (2006) 108 (11): 3754.

https://doi.org/10.1182/blood.V108.11.3754.3754

Published: 2006

NARROW

Safety and Efficacy Trial of Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells (HPCs) for Globin Gene Transfer in Patients with Sickle Cell Disease

Systematic Combinatorial Chimeric Antigen Receptor Therapies to AML

PRMT5 Methyltransferase Activity Is Required to Sustain Adult Hematopoiesis

L3MBTL1: A Polycomb Protein At the Node of Crosstalk Between the BMP4 and Hippo Signaling Pathways in Erythropoiesis.

IPS Cells From Del(7q)-MDS Patients Display Impaired Proliferation and Hematopoietic Commitment

Regulation of AML1/RUNX1 Function by Protein Arginine Methyltransferase 4 (PRMT4) in Myeloid Differentiation

ASXL1 Mutations Promote Myeloid Transformation Through Inhibition of PRC2-Mediated Gene Repression

Targeting a Novel Epigenetic Silencing Mechanism to Efficiently Upregulate Fetal Globin Gene Expression

Methylation of RUNX1 by the Nuclear PRMT5/COPR5 Complex Regulates Its Cellular Location in Leukemia Cells,

The Acetylation of AML1-ETO Is Required for Leukemogenesis.

Liposomal Cytarabine (Depocyte®) for the Treatment of Meningeal or CNS Disease in Acute Leukemias (AL) and Non-Hodgkin Lymphomas (NHL): A Single Centre Experience.

Subcutaneous Alemtuzumab as Treatment Option for Patients with Severe Aplastic Anemia or Lineage-Restricted Aplasia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only